Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. (Q36489415)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. |
scientific article |
Statements
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144 (English)
Merlin L Robb
Nelson L Michael
Jerome H Kim
Supachai Rerks-Ngarm
Peter Gilbert
Sorachai Nitayaphan
Punnee Pitisuttithum
Michael Benenson
Sanjay Gurunathan
Prayura Kunasol
Jim Tartaglia
Chirasak Khamboonruang
Prasert Thongcharoen
Patricia Morgan
Robert M Paris
Joseph Chiu
Elizabeth Adams
Donald Francis
1 reference
1 reference
1 reference
1 reference